companies / cyted-health
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-19 json
| total_raised | 100,000,000100.0M | ○ |
|---|---|---|
| founded | 2018 | |
| hq | Cambridge | |
| industry | unknown | |
| stage | series-b+ |
Cyted Health pairs a swallowable sponge-on-a-string cell collector with AI and molecular biomarkers for early cancer signs. It serves clinicians screening chronic-reflux patients for Barrett's esophagus. Its EndoSign test detects ten times as many cases as standard care, reaching 30,000 UK patients.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-09-01 | series-b | 44,000,00044.0M | null | ○ |
| fact | status | src |
|---|---|---|
| Series B, $44.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |